0 items USD 0.00Search
- Did you mean
- company report (telecom)
Your search for "Company Reports (Telecom)" gave back 13 results.
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Dr. Reddy鈥檚 Laboratories is an India based multinational...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
颁补迟补濒辞驳:听
NAVADHI
June 2019
Price: USD 200.00
Bioplus Life Sciences Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary Bioplus Life Sciences Pvt Ltd - Strategy, SWOT and Corporate...
麻豆原创Line
October 2022
Price: USD 175.00
Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of...
麻豆原创Line
January 2023
Price: USD 175.00
Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report Summary Dr. Reddy's Laboratories Limited - Strategy, SWOT...
麻豆原创Line
March 2022
Price: USD 175.00
听
